Comparison · NCT04692467-bb8ddf6e
Intervention (Early Hypertension) vs Standard of Care: Number of Participants Who Are Enrolled at Baseline and Remain in the Study by 12 Months
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Intervention (Early Hypertension) vs Standard of Care: Number of Participants Who Are Enrolled at Baseline and Remain in the Study by 12 Months. Trial comparisons, record NCT04692467-bb8ddf6e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04692467-bb8ddf6e
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.984 | 0.943 | 0.996 | wilson | |
| Risk in group 2 | 0.968 | 0.92 | 0.987 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0161 | -0.0291 | 0.0653 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.02 | 0.978 | 1.06 | log | |
| Odds ratio, group 1 over group 2 | 2.03 | 0.366 | 11.3 | log | |
| Number needed to treat, for one more participant with the outcome on Intervention (Early Hypertension) than on Standard of Care | 62 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: standard of care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Intervention (Early Hypertension) | Participants randomized to the early HTN treatment arm will initiate 5mg daily of amlodipine immediately, increasing to 10 mg if SBP \>130 mmHg after 1 month.~Amlodipine 5mg: Amlodipine, Haiti's first-line antihypertensive medication, will be administered to the intervention group. | 122 | 124 | OG000 |
| Group 2 | Standard of Care | Participants randomized to the SOC arm will not be initiated on any medications initially. They may be initiated on amlodipine only if they develop HTN (SBP ≥140 or DBP ≥90 mm Hg). | 120 | 124 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants Who Are Enrolled at Baseline and Remain in the Study by 12 Months
- Description
- All participants were included in enrolment. Remaining in the study was defined as having a clinic visit at month 12 (final study visit).
- Time frame
- Baseline, 12 months
- Population
- 2 participants in the standard of care arm were excluded from analysis because these participants died of causes unrelated to the research prior to follow-up month 12.
Source ClinicalTrials.gov
Trial
- Title
- Treatment of Early Hypertension Among Persons Living With HIV in Haiti
- NCT number
- NCT04692467
- Phases
- PHASE2
- Conditions
- HIV/AIDS, Pre Hypertension
- Interventions
- Amlodipine 5mg
- Lead sponsor
- Weill Medical College of Cornell University
- Results first posted
- 2024-04-09
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT04692467?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT04692467-bb8ddf6e